Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic Complications

Volume: 73, Issue: 4, Pages: 553 - 565
Published: Mar 5, 2021
Abstract
Rheumatologists increasingly receive consults for patients treated with immune checkpoint inhibitors (ICIs) for cancer. ICIs can cause inflammatory syndromes known as immune-related adverse events (IRAEs). Several rheumatic IRAEs have been reported, including inflammatory arthritis, polymyalgia rheumatica, and myositis. For patients who present with musculoskeletal symptoms while receiving ICI therapy, it is important to have an algorithm for...
Paper Details
Title
Expert Perspective: Immune Checkpoint Inhibitors and Rheumatologic Complications
Published Date
Mar 5, 2021
Journal
Volume
73
Issue
4
Pages
553 - 565
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.